Criteria for Therapeutic Drug Monitoring

0
3
Read Time:1 Minute, 18 Second

·         The drug in question has a narrow therapeutic range, eg: Lithium, phenytoin, and digoxin
·         A direct relationship exists between the drug or drug metabolite levels in plasma and the pharmacological or toxic effects,
·         The therapeutic effect can not be readily assessed by the clinical observation,

·         Large individual variability in steady state plasma concentration exits at any given dose
·         Appropriate analytic techniques are available to determine the drug and metabolite levels
·         Drugs for which relationship between dose and plasma concentration is unpredictable, e.g Phenytoin
·         Non compliance
·         Therapeutic failure
·         Major organ failure
·         Prevention of adverse drug effects


References

Wells BG, DiPiro J, Schwinghammer T (2013), Pharmacotherapy Handbook (6th Ed). New York, NY: McGraw-Hill.
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey ML, (2008): Pharmacotherapy: A Pathophysiologic Approach (7th ed): New York, NY: McGraw-Hill.

Katz M D., Matthias KR., Chisholm-Burns M A., Pharmacotherapy(2011) Principles & Practice Study Guide: A Case-Based Care Plan Approach: New York, NY: McGraw-Hill.

Schwinghammer TL, Koehler JM (2009) Pharmacotherapy Casebook: A Patient-Focused Approach (7th ed): New York, NY: McGraw-Hill.


Criteria for Therapeutic Drug Monitoring 1 0 Criteria for Therapeutic Drug Monitoring 2 0
Criteria for Therapeutic Drug Monitoring 3

About Post Author

dominicbaitani

Is a content Creator, Website Developer Also is an expert in Advanced Digital Marketing
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleppy
Sleppy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.